Results 111 to 120 of about 11,886 (196)

Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report

Clinical Pharmacology: Advances and Applications, 2011
Maro Ohanian, Christian Cable, Kathleen Halka Department of Hematology/Oncology, Scott & White Healthcare and The Texas A&M Health Science Center, College of Medicine, Temple, TX, USA Objective: To describe how maintenance eculizumab ...
Halka K, Cable C, Ohanian M
doaj  

Therapie von Patienten mit paroxysmaler nächtlicher Hämoglobinurie (PNH) mit Eculizumab [PDF]

, 2018
Die paroxysmale nächtliche Hämoglobinurie (PNH) ist eine seltene, erworbene Erkrankung der hämatopoetischen Stammzellen. PNH Erythrozyten zeigen aufgrund des Fehlens GPI-verankerter komplementregulierender Oberflächenproteine eine erhöhte Anfälligkeit ...
Girmann, Olga
core  

Therapeutic advances in eculizumab for atypical hemolytic uremic syndrome: a narrative review. [PDF]

Front Pharmacol
Zhang D, Xiao Y, Ma H.
europepmc   +1 more source

Thrombotic Events in Patients With Paroxysmal Nocturnal Haemoglobinuria Using Eculizumab: A Post-Marketing Surveillance Sub-Analysis. [PDF]

EJHaem
Ikezoe T, Kawaguchi T, Hayashi H, Shimono A, Nishimura JI.   +4 more
europepmc   +1 more source

Successful rescue therapy with eculizumab for probable tislelizumab-related MMM overlap syndrome with dual positivity for anti-acetylcholine receptor and anti-titin antibodies: a case report and literature review. [PDF]

Front Immunol
Li YX, Hao YL.
europepmc   +1 more source

C5 inhibition restores B cell homeostasis and humoral immunity in CHAPLE disease patients. [PDF]

J Hum Immun
Tahiat A, Belbouab R, Yagoubi A, Buta Panov S, Cuollo L, Djenouhat K, Bogunovic D.   +6 more
europepmc   +1 more source

Efficacy and Safety of Treatments for Paroxysmal Nocturnal Hemoglobinuria: A Systematic Literature Review. [PDF]

J Clin Med
Gandhi S, Munro I, Shodimu V, Webb N, Pannagl K, Wiyani A, Balp MM.   +6 more
europepmc   +1 more source

Atypical Hemolytic Uremic Syndrome in Children and Adults With the Hot Spot C3 Gene Variant p.Arg161Trp. [PDF]

Kidney Int Rep
Ter Steeg L, Bouwmeester RN, Ter Avest M, Bemelman FJ, Bouts AHM, Bredewold OW, Dorresteijn E, Eijgelsheim M, Engels FAPT, Gracchi V, Heine RT, Keijzer-Veen MG, van de Logt AE, van der Meijden WAG, van Rooij RWG, Severs D, Timmermans SAMEG, van Zuilen AD, Michels MAHM, Wijnsma KL, van den Heuvel LPWJ, Wetzels JFM, Duineveld C, van de Kar NCAJ.   +23 more
europepmc   +1 more source

Complement C5 inhibition in generalized myasthenia gravis is associated with improved survival and increased cardiovascular risk. [PDF]

Front Immunol
Vahldieck C, Fels B.
europepmc   +1 more source

Evaluating the treatment of patients with paroxysmal nocturnal hemoglobinuria in Brazil: disparities in access and treatment persistence. [PDF]

Hematol Transfus Cell Ther
Cançado RD, de Melo Campos P, Kashiura D, Thies F, Ferreira E, de Almeida ABM, Leonel LP, Cortez LV, Melo N, Fedozzi F, Bigoni A.   +10 more
europepmc   +1 more source